Cargando…
Treatment with sorafenib plus camrelizumab after splenectomy for primary splenic angiosarcoma with liver metastasis: A case report and literature review
BACKGROUND: Primary splenic angiosarcoma (PSA) is an extremely rare and aggressive mesenchymal malignancy with high metastatic potential and a poor prognosis. There are no established treatment guidelines for PSA, even for adjuvant therapy. This rare case may provide a reliable therapeutic regime fo...
Autores principales: | Pan, Dan, Li, Tai-Ping, Xiong, Jian-Hui, Wang, Shu-Bo, Chen, Yao-Xu, Li, Jian-Feng, Xiao, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968800/ https://www.ncbi.nlm.nih.gov/pubmed/35434106 http://dx.doi.org/10.12998/wjcc.v10.i9.2818 |
Ejemplares similares
-
A primary splenic angiosarcoma hepatic metastasis after splenectomy and its genomic alteration profile
por: Cao, Linping, et al.
Publicado: (2019) -
Splenic Angiosarcoma: A Diagnostic Splenectomy Finding
por: de Azevedo, Otavio Schmidt, et al.
Publicado: (2016) -
Camrelizumab Plus Sorafenib Versus Sorafenib Monotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Analysis
por: Liu, Qinqin, et al.
Publicado: (2021) -
Splenectomy for solitary splenic metastasis of ovarian cancer
por: Koh, Yang Seok, et al.
Publicado: (2004) -
Splenectomy for Splenic Cyst
por: Fraser, F. C.
Publicado: (1933)